Anssi Haikarainen
Inventor
Stats
- 7 US patents issued
- 15 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 7 US Patents Issued
- 15 US Applications Filed
- 30 Total Citation Count
- Jun 28, 2017 Most Recent Filing
- Dec 28, 2007 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
ORION CORPORATION | 2
| 2014
|
BOREALIS AG | 2
4 1 1 | 2009
2011 2012 2014 |
BOREALIS AG | 2
| 2010
|
BOREALIS TECHNOLOGY OY | 1
5 2 | 2007
2008 2012 |
Inventor Addresses
Address | Duration |
---|---|
Järvenpää, FI | May 12, 16 - May 23, 19 |
Tuusula, FI | Aug 26, 10 - Sep 15, 20 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 1 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 2 |
B01J: | CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS, COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS | 5 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
10774074 | 2020 | 2-(1-heteroarylpiperazin-4-yl)methyl-1,4-benzodioxane derivatives as alpha2C antagonists | 0 |
2019/0292,170 | 2019 | 2-(1-HETEROARYLPIPERAZIN-4-YL)METHYL-1,4-BENZODIOXANE DERIVATIVES AS ALPHA2C ANTAGONISTS | 0 |
2019/0152,992 | 2019 | BENZODIOXANE DERIVATIVES AND THEIR PHARMACEUTICAL USE | 0 |
2018/0215,739 | 2018 | 2-(1-HETEROARYLPIPERAZIN-4-YL)METHYL-1,4-BENZODIOXANE DERIVATIVES AS ALPHA2C ANTAGONISTS | 0 |
9890139 | 2018 | CYP17 inhibitors/antiandrogens | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.